Clinical Trial Update: PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating PSCA-targeting CAR-T cells with or without radiation in patients with PSCA-expressing metastatic castration-resistant prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• PSCA-targeting CAR-T cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Status: RECRUITING